FDA Brief

Warning letters Drugs

FDA warning letter to

Pinnacle Professional Research dba Pinnacle Peptides

High riskIssued Dec 12, 2025Posted Dec 23, 2025Center for Drug Evaluation and Research (CDER)

FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.

What happened

FDA reviewed the company's website in November 2025 and found it selling products marketed as selective androgen receptor modulators (SARMs) — compounds promoted to build muscle and treat conditions like osteoporosis and cancer. FDA says the products are drugs intended for human use despite "FOR RESEARCH ONLY" labels, and that they have no approved drug application. FDA also cited safety concerns including life-threatening liver toxicity and increased risk of heart attack and stroke.

What FDA found

  1. The company sells SARMs as drugs for human use without any FDA-approved application, which is illegal.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  2. Website claims that the products treat osteoporosis, cancer, muscle loss and other conditions show they are intended as drugs.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128
  3. "For research only" and "not for human use" statements do not cancel out the website's claims of human benefit.

    21 CFR 201.128
  4. The products are "new drugs" because they are not generally recognized as safe and effective for the uses described in their labeling.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  5. Shipping these unapproved drugs across state lines is prohibited.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)

What FDA wants

FDA asks the company to write within fifteen working days describing the specific steps taken to fix the violations and prevent them from happening again, or to explain why it believes the products are lawful. If corrections cannot be finished in that time, the company must say why and give a completion date.

Who should pay attention

  • online sellers of SARMs and "research only" peptides
  • companies whose payment processors or web hosts serve such sellers
  • consumers and athletes buying SARMs online

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk